Bexson Biomedical
Bexson Biomedical: Developing non-opioid therapies for effective pain management.
Founded
2016Bexson Biomedical: Developing non-opioid therapies for effective pain management.
Bexson Biomedical, founded with the mission to combat opioid addiction through innovative pain management solutions, focuses on developing non-opioid therapies. The company aims to provide effective relief for patients while reducing the dependency on opioids. Their core product includes SeVALENT™, a patented drug delivery platform for small molecules, and an on-body subcutaneous delivery system designed for home health use. Bexson Biomedical's market focus is on revolutionizing pain management and enhancing patient lives through advanced medical technologies.
Notable figures affiliated with Bexson Biomedical include experts in biopharmaceutical innovation and healthcare technology. The company has attracted significant interest from investors focused on transformative healthcare solutions. Key achievements include the development and patenting of their SeVALENT™ technology and the introduction of their wearable drug delivery device. Bexson Biomedical's impact lies in its potential to significantly reduce opioid addiction rates by providing safer, non-opioid alternatives for pain management, thereby improving overall public health outcomes.
Companies similar to Bexson Biomedical include Latigo Biotherapeutics, Centrexion Therapeutics, Maxona Pharmaceuticals and Concentric Analgesics.
Bexson Biomedical was founded in 2016.
Bexson Biomedical's headquarters is located in Santa Barbara, CA, US.
Bexson Biomedical's most recent funding round was for $4.8M (USD) in February 2021.
As of Feb 2, 2021, Bexson Biomedical has raised a total of $4.8M (USD).
Bexson Biomedical has 35 employees as of Feb 4, 2024.
Maxona Pharmaceuticals
maxonapharm.com
